190 related articles for article (PubMed ID: 9597967)
1. Unconventional therapies for cancer: 3. Iscador. Task Force on Alternative Therapies of the Canadian Breast Cancer Research Initiative.
Kaegi E
CMAJ; 1998 May; 158(9):1157-9. PubMed ID: 9597967
[No Abstract] [Full Text] [Related]
2. [Mistletoe therapy. An alternative cancer treatment].
Ernst E
MMW Fortschr Med; 2000 Nov; 142(45):52-3. PubMed ID: 11107826
[No Abstract] [Full Text] [Related]
3. [Favorable long-term outcome with mistletoe therapy in a patient with centroblastic-centrocytic non hodgkin lymphoma].
Pierach CA
Dtsch Med Wochenschr; 2000 Aug; 125(31-32):958-60. PubMed ID: 10967963
[No Abstract] [Full Text] [Related]
4. Use of Iscador, an extract of European mistletoe (Viscum album), in cancer treatment: prospective nonrandomized and randomized matched-pair studies nested within a cohort study.
Grossarth-Maticek R; Kiene H; Baumgartner SM; Ziegler R
Altern Ther Health Med; 2001; 7(3):57-66, 68-72, 74-6 passim. PubMed ID: 11347286
[TBL] [Abstract][Full Text] [Related]
5. Unconventional therapies for cancer: 2. Green tea. The Task Force on Alternative Therapies of the Canadian Breast Cancer Research Initiative.
Kaegi E
CMAJ; 1998 Apr; 158(8):1033-5. PubMed ID: 9580732
[No Abstract] [Full Text] [Related]
6. [Iscador--mistletoe extract for cancer treatment. Documentation No. 10].
Schweiz Rundsch Med Prax; 1988 Jan; 77(4):69-74. PubMed ID: 3279479
[No Abstract] [Full Text] [Related]
7. Pleura carcinosis. Cytomorphological findings with the mistletoe preparation iscador and other pharmaceuticals.
Salzer G
Oncology; 1986; 43 Suppl 1():66-70. PubMed ID: 3808576
[TBL] [Abstract][Full Text] [Related]
8. Evaluating unconventional therapies.
Hajto T; Saller R
CMAJ; 1998 Oct; 159(7):759; author reply 759, 761. PubMed ID: 9805018
[No Abstract] [Full Text] [Related]
9. Mistletoe in immunology and the clinic (short review).
Stein GM; Schietzel M; Büssing A
Anticancer Res; 1998; 18(5A):3247-9. PubMed ID: 9858890
[TBL] [Abstract][Full Text] [Related]
10. [Metaphorical aspects of mistletoe therapy in patients' experiences--a qualitative study].
Konitzer M; Doering T; Fischer GC
Forsch Komplementarmed Klass Naturheilkd; 2001 Apr; 8(2):68-79. PubMed ID: 11340313
[TBL] [Abstract][Full Text] [Related]
11. Prospective controlled cohort studies on long-term therapy of breast cancer patients with a mistletoe preparation (Iscador).
Grossarth-Maticek R; Ziegler R
Forsch Komplementmed; 2006 Oct; 13(5):285-92. PubMed ID: 17057389
[TBL] [Abstract][Full Text] [Related]
12. Anticarcinogenic and antimetastatic activity of Iscador.
Kuttan G; Menon LG; Antony S; Kuttan R
Anticancer Drugs; 1997 Apr; 8 Suppl 1():S15-6. PubMed ID: 9179361
[TBL] [Abstract][Full Text] [Related]
13. [Value of mistletoe therapy in carcinoma patients].
Rostock M; Unger C
Internist (Berl); 1998 Dec; 39(12):1294-5. PubMed ID: 10198836
[No Abstract] [Full Text] [Related]
14. Where are cancer survivors in the Iscador study?
Yarger L
Altern Ther Health Med; 2001; 7(4):18. PubMed ID: 11452558
[No Abstract] [Full Text] [Related]
15. [Mistletoe therapy in cancer treatment: pros and cons].
Wiebelitz KR; Beer AM; Heinrich B
MMW Fortschr Med; 2009 Nov; 151(46):30-1. PubMed ID: 20043390
[No Abstract] [Full Text] [Related]
16. Prospective controlled cohort studies on long-term therapy of ovairian cancer patients with mistletoe (Viscum album L.) extracts iscador.
Grossarth-Maticek R; Ziegler R
Arzneimittelforschung; 2007; 57(10):665-78. PubMed ID: 18074761
[TBL] [Abstract][Full Text] [Related]
17. [Possibilities and limits of mistletoe therapy in cancer patients].
Hoffmann J
Arch Gynecol Obstet; 1987; 242(1-4):257-60. PubMed ID: 3688952
[No Abstract] [Full Text] [Related]
18. [Anthroposophy. Mistletoe preparations: a cancer inhibiting wonder drug?].
Arm F
Krankenpfl Soins Infirm; 1989 May; 82(5):18-21. PubMed ID: 2747189
[No Abstract] [Full Text] [Related]
19. [On the prescription of injection preparations Iscador and Helixor].
Holmberg K
Lakartidningen; 2000 Sep; 97(38):4182, 4185. PubMed ID: 11068394
[No Abstract] [Full Text] [Related]
20. Randomised and non-randomised prospective controlled cohort studies in matched-pair design for the long-term therapy of breast cancer patients with a mistletoe preparation (Iscador): a re-analysis.
Grossarth-Maticek R; Ziegler R
Eur J Med Res; 2006 Nov; 11(11):485-95. PubMed ID: 17182361
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
